hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance

Barrett's esophagus (BE) is the only well-known precursor lesion of esophageal adenocarcinoma (EA). The exact estimates of the annual progression rate from BE to EA vary from 0.07% to 3.6%. The identification of BE patients at higher risk to progress to EA is hence mandatory, although difficult...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Lastraioli, Elena, Lottini, Tiziano, Iorio, Jessica, Freschi, Giancarlo, Fazi, Marilena, Duranti, Claudia, Carraresi, Laura, Messerini, Luca, Taddei, Antonio, Ringressi, Maria Novella, Salemme, Marianna, Villanacci, Vincenzo, Vindigni, Carla, Tomezzoli, Anna, Mendola, Roberta La, Bencivenga, Maria, Compagnoni, Bruno, Chiudinelli, Mariella, Saragoni, Luca, Manzi, Ilaria, Manzoni, Giovanni De, Bechi, Paolo, Boni, Luca, Arcangeli, Annarosa
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5312329/
https://ncbi.nlm.nih.gov/pubmed/27517748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11149
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados